nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP2E1—type 2 diabetes mellitus	0.193	0.614	CbGaD
Mitoxantrone—CYP3A4—type 2 diabetes mellitus	0.122	0.386	CbGaD
Mitoxantrone—SLC47A1—Metformin—type 2 diabetes mellitus	0.0753	0.198	CbGbCtD
Mitoxantrone—ABCC1—Glyburide—type 2 diabetes mellitus	0.0424	0.112	CbGbCtD
Mitoxantrone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.031	0.0816	CbGbCtD
Mitoxantrone—ABCG2—Glyburide—type 2 diabetes mellitus	0.0284	0.0747	CbGbCtD
Mitoxantrone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0277	0.0728	CbGbCtD
Mitoxantrone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.02	0.0526	CbGbCtD
Mitoxantrone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0186	0.0489	CbGbCtD
Mitoxantrone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0166	0.0436	CbGbCtD
Mitoxantrone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0152	0.0399	CbGbCtD
Mitoxantrone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0137	0.0361	CbGbCtD
Mitoxantrone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0132	0.0348	CbGbCtD
Mitoxantrone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.012	0.0315	CbGbCtD
Mitoxantrone—ABCB1—Glyburide—type 2 diabetes mellitus	0.0102	0.0269	CbGbCtD
Mitoxantrone—ABCB1—Losartan—type 2 diabetes mellitus	0.00936	0.0246	CbGbCtD
Mitoxantrone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00908	0.0239	CbGbCtD
Mitoxantrone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0087	0.0229	CbGbCtD
Mitoxantrone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0087	0.0229	CbGbCtD
Mitoxantrone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00823	0.0217	CbGbCtD
Mitoxantrone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00613	0.0161	CbGbCtD
Mitoxantrone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00561	0.0148	CbGbCtD
Mitoxantrone—SLC47A2—kidney—type 2 diabetes mellitus	0.00197	0.0676	CbGeAlD
Mitoxantrone—SLC47A2—cortex of kidney—type 2 diabetes mellitus	0.00192	0.0658	CbGeAlD
Mitoxantrone—PIM1—islet of Langerhans—type 2 diabetes mellitus	0.00182	0.0624	CbGeAlD
Mitoxantrone—PIM1—nephron tubule—type 2 diabetes mellitus	0.00146	0.0502	CbGeAlD
Mitoxantrone—BTK—adipose tissue—type 2 diabetes mellitus	0.00134	0.0459	CbGeAlD
Mitoxantrone—PIM1—cardiovascular system—type 2 diabetes mellitus	0.00131	0.0451	CbGeAlD
Mitoxantrone—PIM1—kidney—type 2 diabetes mellitus	0.00129	0.0441	CbGeAlD
Mitoxantrone—PIM1—pancreas—type 2 diabetes mellitus	0.00128	0.0439	CbGeAlD
Mitoxantrone—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00127	0.724	CbGdCrCtD
Mitoxantrone—PIM1—cortex of kidney—type 2 diabetes mellitus	0.00125	0.043	CbGeAlD
Mitoxantrone—PIM1—adipose tissue—type 2 diabetes mellitus	0.00116	0.0398	CbGeAlD
Mitoxantrone—BTK—liver—type 2 diabetes mellitus	0.000938	0.0322	CbGeAlD
Mitoxantrone—PIM1—liver—type 2 diabetes mellitus	0.000812	0.0279	CbGeAlD
Mitoxantrone—SLC47A1—nephron tubule—type 2 diabetes mellitus	0.000784	0.0269	CbGeAlD
Mitoxantrone—SLC47A1—kidney—type 2 diabetes mellitus	0.000689	0.0237	CbGeAlD
Mitoxantrone—TOP2A—adipose tissue—type 2 diabetes mellitus	0.00068	0.0233	CbGeAlD
Mitoxantrone—SLC47A1—cortex of kidney—type 2 diabetes mellitus	0.000671	0.023	CbGeAlD
Mitoxantrone—SLC47A1—adipose tissue—type 2 diabetes mellitus	0.000621	0.0213	CbGeAlD
Mitoxantrone—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000574	0.0197	CbGeAlD
Mitoxantrone—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000516	0.0177	CbGeAlD
Mitoxantrone—CYP1B1—kidney—type 2 diabetes mellitus	0.000505	0.0173	CbGeAlD
Mitoxantrone—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000492	0.0169	CbGeAlD
Mitoxantrone—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000484	0.276	CbGdCrCtD
Mitoxantrone—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000455	0.0156	CbGeAlD
Mitoxantrone—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000442	0.0152	CbGeAlD
Mitoxantrone—SLC47A1—liver—type 2 diabetes mellitus	0.000435	0.0149	CbGeAlD
Mitoxantrone—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000428	0.0147	CbGeAlD
Mitoxantrone—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000409	0.0141	CbGeAlD
Mitoxantrone—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.00037	0.0127	CbGeAlD
Mitoxantrone—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000339	0.0116	CbGeAlD
Mitoxantrone—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000333	0.0114	CbGeAlD
Mitoxantrone—CYP2E1—kidney—type 2 diabetes mellitus	0.000325	0.0112	CbGeAlD
Mitoxantrone—CYP1B1—liver—type 2 diabetes mellitus	0.000319	0.011	CbGeAlD
Mitoxantrone—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000317	0.0109	CbGeAlD
Mitoxantrone—ABCC1—liver—type 2 diabetes mellitus	0.000287	0.00986	CbGeAlD
Mitoxantrone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000262	0.009	CbGeAlD
Mitoxantrone—CYP3A4—kidney—type 2 diabetes mellitus	0.000262	0.00899	CbGeAlD
Mitoxantrone—ABCG2—liver—type 2 diabetes mellitus	0.000238	0.00816	CbGeAlD
Mitoxantrone—ABCB1—retina—type 2 diabetes mellitus	0.000224	0.00769	CbGeAlD
Mitoxantrone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000211	0.00724	CbGeAlD
Mitoxantrone—CYP2E1—liver—type 2 diabetes mellitus	0.000206	0.00706	CbGeAlD
Mitoxantrone—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000189	0.00651	CbGeAlD
Mitoxantrone—ABCB1—kidney—type 2 diabetes mellitus	0.000185	0.00637	CbGeAlD
Mitoxantrone—ABCB1—pancreas—type 2 diabetes mellitus	0.000184	0.00632	CbGeAlD
Mitoxantrone—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.00018	0.0062	CbGeAlD
Mitoxantrone—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000167	0.00574	CbGeAlD
Mitoxantrone—CYP3A4—liver—type 2 diabetes mellitus	0.000165	0.00568	CbGeAlD
Mitoxantrone—ABCB1—liver—type 2 diabetes mellitus	0.000117	0.00402	CbGeAlD
Mitoxantrone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000109	0.000625	CcSEcCtD
Mitoxantrone—Hypertension—Metformin—type 2 diabetes mellitus	0.000108	0.000622	CcSEcCtD
Mitoxantrone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000108	0.000622	CcSEcCtD
Mitoxantrone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000108	0.00062	CcSEcCtD
Mitoxantrone—Back pain—Losartan—type 2 diabetes mellitus	0.000108	0.000619	CcSEcCtD
Mitoxantrone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000108	0.000619	CcSEcCtD
Mitoxantrone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000619	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000107	0.000617	CcSEcCtD
Mitoxantrone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000107	0.000616	CcSEcCtD
Mitoxantrone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000614	CcSEcCtD
Mitoxantrone—Chest pain—Metformin—type 2 diabetes mellitus	0.000107	0.000613	CcSEcCtD
Mitoxantrone—Myalgia—Metformin—type 2 diabetes mellitus	0.000107	0.000613	CcSEcCtD
Mitoxantrone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000107	0.000613	CcSEcCtD
Mitoxantrone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000106	0.00061	CcSEcCtD
Mitoxantrone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000609	CcSEcCtD
Mitoxantrone—Discomfort—Metformin—type 2 diabetes mellitus	0.000106	0.000606	CcSEcCtD
Mitoxantrone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000106	0.000606	CcSEcCtD
Mitoxantrone—Nausea—Glipizide—type 2 diabetes mellitus	0.000105	0.000604	CcSEcCtD
Mitoxantrone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000105	0.000604	CcSEcCtD
Mitoxantrone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000105	0.000603	CcSEcCtD
Mitoxantrone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000105	0.000603	CcSEcCtD
Mitoxantrone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000602	CcSEcCtD
Mitoxantrone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000105	0.000601	CcSEcCtD
Mitoxantrone—Pain—Gliclazide—type 2 diabetes mellitus	0.000105	0.000601	CcSEcCtD
Mitoxantrone—Rash—Glimepiride—type 2 diabetes mellitus	0.000104	0.000598	CcSEcCtD
Mitoxantrone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000104	0.000598	CcSEcCtD
Mitoxantrone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000104	0.000597	CcSEcCtD
Mitoxantrone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000104	0.000596	CcSEcCtD
Mitoxantrone—Headache—Glimepiride—type 2 diabetes mellitus	0.000104	0.000595	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000103	0.000594	CcSEcCtD
Mitoxantrone—Cough—Irbesartan—type 2 diabetes mellitus	0.000103	0.000593	CcSEcCtD
Mitoxantrone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000593	CcSEcCtD
Mitoxantrone—Anaemia—Losartan—type 2 diabetes mellitus	0.000103	0.000591	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000102	0.000588	CcSEcCtD
Mitoxantrone—Oedema—Metformin—type 2 diabetes mellitus	0.000102	0.000588	CcSEcCtD
Mitoxantrone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000102	0.000587	CcSEcCtD
Mitoxantrone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000586	CcSEcCtD
Mitoxantrone—Infection—Metformin—type 2 diabetes mellitus	0.000102	0.000584	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000101	0.000581	CcSEcCtD
Mitoxantrone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000101	0.00058	CcSEcCtD
Mitoxantrone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000101	0.000579	CcSEcCtD
Mitoxantrone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000579	CcSEcCtD
Mitoxantrone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000101	0.000579	CcSEcCtD
Mitoxantrone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000101	0.000579	CcSEcCtD
Mitoxantrone—Shock—Metformin—type 2 diabetes mellitus	0.000101	0.000579	CcSEcCtD
Mitoxantrone—Malaise—Losartan—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Mitoxantrone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.0001	0.000577	CcSEcCtD
Mitoxantrone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0001	0.000577	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.0001	0.000576	CcSEcCtD
Mitoxantrone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.0001	0.000576	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.0001	0.000575	CcSEcCtD
Mitoxantrone—Somnolence—Valsartan—type 2 diabetes mellitus	0.0001	0.000574	CcSEcCtD
Mitoxantrone—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.98e-05	0.000573	CcSEcCtD
Mitoxantrone—Leukopenia—Losartan—type 2 diabetes mellitus	9.98e-05	0.000573	CcSEcCtD
Mitoxantrone—Discomfort—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000572	CcSEcCtD
Mitoxantrone—Skin disorder—Metformin—type 2 diabetes mellitus	9.95e-05	0.000571	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.9e-05	0.000569	CcSEcCtD
Mitoxantrone—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000568	CcSEcCtD
Mitoxantrone—Nausea—Glimepiride—type 2 diabetes mellitus	9.82e-05	0.000564	CcSEcCtD
Mitoxantrone—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000563	CcSEcCtD
Mitoxantrone—Nausea—Sitagliptin—type 2 diabetes mellitus	9.79e-05	0.000562	CcSEcCtD
Mitoxantrone—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000562	CcSEcCtD
Mitoxantrone—Asthenia—Glyburide—type 2 diabetes mellitus	9.78e-05	0.000562	CcSEcCtD
Mitoxantrone—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.78e-05	0.000561	CcSEcCtD
Mitoxantrone—Anorexia—Metformin—type 2 diabetes mellitus	9.76e-05	0.000561	CcSEcCtD
Mitoxantrone—Cough—Losartan—type 2 diabetes mellitus	9.73e-05	0.000558	CcSEcCtD
Mitoxantrone—Urticaria—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.000558	CcSEcCtD
Mitoxantrone—Alopecia—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000557	CcSEcCtD
Mitoxantrone—Fatigue—Valsartan—type 2 diabetes mellitus	9.7e-05	0.000557	CcSEcCtD
Mitoxantrone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.68e-05	0.000556	CcSEcCtD
Mitoxantrone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.68e-05	0.000556	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000555	CcSEcCtD
Mitoxantrone—Oedema—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000555	CcSEcCtD
Mitoxantrone—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.66e-05	0.000555	CcSEcCtD
Mitoxantrone—Constipation—Valsartan—type 2 diabetes mellitus	9.62e-05	0.000552	CcSEcCtD
Mitoxantrone—Infection—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000551	CcSEcCtD
Mitoxantrone—Fatigue—Orlistat—type 2 diabetes mellitus	9.58e-05	0.00055	CcSEcCtD
Mitoxantrone—Hypotension—Metformin—type 2 diabetes mellitus	9.57e-05	0.00055	CcSEcCtD
Mitoxantrone—Erythema—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000549	CcSEcCtD
Mitoxantrone—Shock—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000546	CcSEcCtD
Mitoxantrone—Pain—Orlistat—type 2 diabetes mellitus	9.5e-05	0.000546	CcSEcCtD
Mitoxantrone—Arthralgia—Losartan—type 2 diabetes mellitus	9.49e-05	0.000545	CcSEcCtD
Mitoxantrone—Chest pain—Losartan—type 2 diabetes mellitus	9.49e-05	0.000545	CcSEcCtD
Mitoxantrone—Myalgia—Losartan—type 2 diabetes mellitus	9.49e-05	0.000545	CcSEcCtD
Mitoxantrone—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.48e-05	0.000544	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.46e-05	0.000543	CcSEcCtD
Mitoxantrone—Anxiety—Losartan—type 2 diabetes mellitus	9.46e-05	0.000543	CcSEcCtD
Mitoxantrone—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000542	CcSEcCtD
Mitoxantrone—Rash—Bromocriptine—type 2 diabetes mellitus	9.4e-05	0.00054	CcSEcCtD
Mitoxantrone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.4e-05	0.000539	CcSEcCtD
Mitoxantrone—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000539	CcSEcCtD
Mitoxantrone—Discomfort—Losartan—type 2 diabetes mellitus	9.38e-05	0.000538	CcSEcCtD
Mitoxantrone—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.36e-05	0.000537	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.000537	CcSEcCtD
Mitoxantrone—Headache—Bromocriptine—type 2 diabetes mellitus	9.34e-05	0.000536	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.33e-05	0.000536	CcSEcCtD
Mitoxantrone—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.33e-05	0.000536	CcSEcCtD
Mitoxantrone—Anorexia—Irbesartan—type 2 diabetes mellitus	9.21e-05	0.000529	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.2e-05	0.000528	CcSEcCtD
Mitoxantrone—Paraesthesia—Metformin—type 2 diabetes mellitus	9.2e-05	0.000528	CcSEcCtD
Mitoxantrone—Confusional state—Losartan—type 2 diabetes mellitus	9.17e-05	0.000527	CcSEcCtD
Mitoxantrone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.16e-05	0.000526	CcSEcCtD
Mitoxantrone—Dyspnoea—Metformin—type 2 diabetes mellitus	9.13e-05	0.000524	CcSEcCtD
Mitoxantrone—Somnolence—Metformin—type 2 diabetes mellitus	9.11e-05	0.000523	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.1e-05	0.000522	CcSEcCtD
Mitoxantrone—Oedema—Losartan—type 2 diabetes mellitus	9.1e-05	0.000522	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.09e-05	0.000522	CcSEcCtD
Mitoxantrone—Infection—Losartan—type 2 diabetes mellitus	9.04e-05	0.000519	CcSEcCtD
Mitoxantrone—Hypotension—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.000519	CcSEcCtD
Mitoxantrone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.02e-05	0.000518	CcSEcCtD
Mitoxantrone—Dyspepsia—Metformin—type 2 diabetes mellitus	9.02e-05	0.000518	CcSEcCtD
Mitoxantrone—Shock—Losartan—type 2 diabetes mellitus	8.95e-05	0.000514	CcSEcCtD
Mitoxantrone—Urticaria—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000513	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.91e-05	0.000511	CcSEcCtD
Mitoxantrone—Decreased appetite—Metformin—type 2 diabetes mellitus	8.9e-05	0.000511	CcSEcCtD
Mitoxantrone—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.89e-05	0.000511	CcSEcCtD
Mitoxantrone—Tachycardia—Losartan—type 2 diabetes mellitus	8.88e-05	0.00051	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000509	CcSEcCtD
Mitoxantrone—Nausea—Bromocriptine—type 2 diabetes mellitus	8.86e-05	0.000509	CcSEcCtD
Mitoxantrone—Fatigue—Metformin—type 2 diabetes mellitus	8.83e-05	0.000507	CcSEcCtD
Mitoxantrone—Urticaria—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000507	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000506	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.79e-05	0.000505	CcSEcCtD
Mitoxantrone—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.79e-05	0.000504	CcSEcCtD
Mitoxantrone—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.79e-05	0.000504	CcSEcCtD
Mitoxantrone—Asthenia—Gliclazide—type 2 diabetes mellitus	8.78e-05	0.000504	CcSEcCtD
Mitoxantrone—Constipation—Metformin—type 2 diabetes mellitus	8.76e-05	0.000503	CcSEcCtD
Mitoxantrone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000498	CcSEcCtD
Mitoxantrone—Anorexia—Losartan—type 2 diabetes mellitus	8.67e-05	0.000498	CcSEcCtD
Mitoxantrone—Vomiting—Glyburide—type 2 diabetes mellitus	8.67e-05	0.000498	CcSEcCtD
Mitoxantrone—Malaise—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000495	CcSEcCtD
Mitoxantrone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000495	CcSEcCtD
Mitoxantrone—Rash—Glyburide—type 2 diabetes mellitus	8.6e-05	0.000494	CcSEcCtD
Mitoxantrone—Somnolence—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000493	CcSEcCtD
Mitoxantrone—Dermatitis—Glyburide—type 2 diabetes mellitus	8.59e-05	0.000493	CcSEcCtD
Mitoxantrone—Leukopenia—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000491	CcSEcCtD
Mitoxantrone—Headache—Glyburide—type 2 diabetes mellitus	8.54e-05	0.00049	CcSEcCtD
Mitoxantrone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000489	CcSEcCtD
Mitoxantrone—Hypotension—Losartan—type 2 diabetes mellitus	8.5e-05	0.000488	CcSEcCtD
Mitoxantrone—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.44e-05	0.000485	CcSEcCtD
Mitoxantrone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000482	CcSEcCtD
Mitoxantrone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.38e-05	0.000481	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.38e-05	0.000481	CcSEcCtD
Mitoxantrone—Cough—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000479	CcSEcCtD
Mitoxantrone—Fatigue—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.000478	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.29e-05	0.000476	CcSEcCtD
Mitoxantrone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.29e-05	0.000476	CcSEcCtD
Mitoxantrone—Convulsion—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000475	CcSEcCtD
Mitoxantrone—Pain—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000475	CcSEcCtD
Mitoxantrone—Constipation—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000475	CcSEcCtD
Mitoxantrone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.19e-05	0.00047	CcSEcCtD
Mitoxantrone—Paraesthesia—Losartan—type 2 diabetes mellitus	8.17e-05	0.000469	CcSEcCtD
Mitoxantrone—Urticaria—Metformin—type 2 diabetes mellitus	8.14e-05	0.000467	CcSEcCtD
Mitoxantrone—Myalgia—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000467	CcSEcCtD
Mitoxantrone—Arthralgia—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000467	CcSEcCtD
Mitoxantrone—Chest pain—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000467	CcSEcCtD
Mitoxantrone—Dyspnoea—Losartan—type 2 diabetes mellitus	8.11e-05	0.000466	CcSEcCtD
Mitoxantrone—Anxiety—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000466	CcSEcCtD
Mitoxantrone—Nausea—Glyburide—type 2 diabetes mellitus	8.1e-05	0.000465	CcSEcCtD
Mitoxantrone—Abdominal pain—Metformin—type 2 diabetes mellitus	8.1e-05	0.000465	CcSEcCtD
Mitoxantrone—Somnolence—Losartan—type 2 diabetes mellitus	8.09e-05	0.000464	CcSEcCtD
Mitoxantrone—Asthenia—Valsartan—type 2 diabetes mellitus	8.07e-05	0.000463	CcSEcCtD
Mitoxantrone—Discomfort—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000462	CcSEcCtD
Mitoxantrone—Dyspepsia—Losartan—type 2 diabetes mellitus	8.01e-05	0.00046	CcSEcCtD
Mitoxantrone—Asthenia—Orlistat—type 2 diabetes mellitus	7.97e-05	0.000458	CcSEcCtD
Mitoxantrone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000457	CcSEcCtD
Mitoxantrone—Decreased appetite—Losartan—type 2 diabetes mellitus	7.91e-05	0.000454	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000454	CcSEcCtD
Mitoxantrone—Confusional state—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000452	CcSEcCtD
Mitoxantrone—Fatigue—Losartan—type 2 diabetes mellitus	7.84e-05	0.00045	CcSEcCtD
Mitoxantrone—Oedema—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000448	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000448	CcSEcCtD
Mitoxantrone—Vomiting—Gliclazide—type 2 diabetes mellitus	7.78e-05	0.000447	CcSEcCtD
Mitoxantrone—Pain—Losartan—type 2 diabetes mellitus	7.78e-05	0.000447	CcSEcCtD
Mitoxantrone—Constipation—Losartan—type 2 diabetes mellitus	7.78e-05	0.000447	CcSEcCtD
Mitoxantrone—Rash—Gliclazide—type 2 diabetes mellitus	7.72e-05	0.000443	CcSEcCtD
Mitoxantrone—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.71e-05	0.000443	CcSEcCtD
Mitoxantrone—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.7e-05	0.000442	CcSEcCtD
Mitoxantrone—Urticaria—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000441	CcSEcCtD
Mitoxantrone—Shock—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000441	CcSEcCtD
Mitoxantrone—Headache—Gliclazide—type 2 diabetes mellitus	7.67e-05	0.00044	CcSEcCtD
Mitoxantrone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000439	CcSEcCtD
Mitoxantrone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000439	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000438	CcSEcCtD
Mitoxantrone—Tachycardia—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000437	CcSEcCtD
Mitoxantrone—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.6e-05	0.000437	CcSEcCtD
Mitoxantrone—Skin disorder—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000435	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000433	CcSEcCtD
Mitoxantrone—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.5e-05	0.00043	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.44e-05	0.000427	CcSEcCtD
Mitoxantrone—Anorexia—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000427	CcSEcCtD
Mitoxantrone—Asthenia—Metformin—type 2 diabetes mellitus	7.35e-05	0.000422	CcSEcCtD
Mitoxantrone—Hypotension—Ramipril—type 2 diabetes mellitus	7.29e-05	0.000418	CcSEcCtD
Mitoxantrone—Nausea—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.000418	CcSEcCtD
Mitoxantrone—Urticaria—Losartan—type 2 diabetes mellitus	7.23e-05	0.000415	CcSEcCtD
Mitoxantrone—Body temperature increased—Losartan—type 2 diabetes mellitus	7.19e-05	0.000413	CcSEcCtD
Mitoxantrone—Abdominal pain—Losartan—type 2 diabetes mellitus	7.19e-05	0.000413	CcSEcCtD
Mitoxantrone—Vomiting—Valsartan—type 2 diabetes mellitus	7.15e-05	0.000411	CcSEcCtD
Mitoxantrone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000409	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000408	CcSEcCtD
Mitoxantrone—Rash—Valsartan—type 2 diabetes mellitus	7.09e-05	0.000407	CcSEcCtD
Mitoxantrone—Dermatitis—Valsartan—type 2 diabetes mellitus	7.09e-05	0.000407	CcSEcCtD
Mitoxantrone—Vomiting—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000406	CcSEcCtD
Mitoxantrone—Headache—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000405	CcSEcCtD
Mitoxantrone—Diarrhoea—Metformin—type 2 diabetes mellitus	7.01e-05	0.000402	CcSEcCtD
Mitoxantrone—Rash—Orlistat—type 2 diabetes mellitus	7.01e-05	0.000402	CcSEcCtD
Mitoxantrone—Paraesthesia—Ramipril—type 2 diabetes mellitus	7e-05	0.000402	CcSEcCtD
Mitoxantrone—Dermatitis—Orlistat—type 2 diabetes mellitus	7e-05	0.000402	CcSEcCtD
Mitoxantrone—Headache—Orlistat—type 2 diabetes mellitus	6.96e-05	0.0004	CcSEcCtD
Mitoxantrone—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000399	CcSEcCtD
Mitoxantrone—Asthenia—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000398	CcSEcCtD
Mitoxantrone—Somnolence—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000398	CcSEcCtD
Mitoxantrone—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000394	CcSEcCtD
Mitoxantrone—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000389	CcSEcCtD
Mitoxantrone—Fatigue—Ramipril—type 2 diabetes mellitus	6.73e-05	0.000386	CcSEcCtD
Mitoxantrone—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.7e-05	0.000385	CcSEcCtD
Mitoxantrone—Nausea—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000384	CcSEcCtD
Mitoxantrone—Constipation—Ramipril—type 2 diabetes mellitus	6.67e-05	0.000383	CcSEcCtD
Mitoxantrone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.61e-05	0.00038	CcSEcCtD
Mitoxantrone—Nausea—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000379	CcSEcCtD
Mitoxantrone—Asthenia—Losartan—type 2 diabetes mellitus	6.53e-05	0.000375	CcSEcCtD
Mitoxantrone—Vomiting—Metformin—type 2 diabetes mellitus	6.51e-05	0.000374	CcSEcCtD
Mitoxantrone—Rash—Metformin—type 2 diabetes mellitus	6.46e-05	0.000371	CcSEcCtD
Mitoxantrone—Dermatitis—Metformin—type 2 diabetes mellitus	6.45e-05	0.00037	CcSEcCtD
Mitoxantrone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000369	CcSEcCtD
Mitoxantrone—Headache—Metformin—type 2 diabetes mellitus	6.42e-05	0.000368	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000366	CcSEcCtD
Mitoxantrone—Diarrhoea—Losartan—type 2 diabetes mellitus	6.22e-05	0.000357	CcSEcCtD
Mitoxantrone—Urticaria—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000356	CcSEcCtD
Mitoxantrone—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000354	CcSEcCtD
Mitoxantrone—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000354	CcSEcCtD
Mitoxantrone—Vomiting—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000353	CcSEcCtD
Mitoxantrone—Rash—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.00035	CcSEcCtD
Mitoxantrone—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.00035	CcSEcCtD
Mitoxantrone—Nausea—Metformin—type 2 diabetes mellitus	6.08e-05	0.000349	CcSEcCtD
Mitoxantrone—Headache—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000348	CcSEcCtD
Mitoxantrone—Vomiting—Losartan—type 2 diabetes mellitus	5.78e-05	0.000332	CcSEcCtD
Mitoxantrone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.75e-05	0.00033	CcSEcCtD
Mitoxantrone—Nausea—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.00033	CcSEcCtD
Mitoxantrone—Rash—Losartan—type 2 diabetes mellitus	5.74e-05	0.000329	CcSEcCtD
Mitoxantrone—Dermatitis—Losartan—type 2 diabetes mellitus	5.73e-05	0.000329	CcSEcCtD
Mitoxantrone—Headache—Losartan—type 2 diabetes mellitus	5.7e-05	0.000327	CcSEcCtD
Mitoxantrone—Asthenia—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000321	CcSEcCtD
Mitoxantrone—Nausea—Losartan—type 2 diabetes mellitus	5.4e-05	0.00031	CcSEcCtD
Mitoxantrone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000306	CcSEcCtD
Mitoxantrone—Vomiting—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000285	CcSEcCtD
Mitoxantrone—Rash—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000282	CcSEcCtD
Mitoxantrone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000282	CcSEcCtD
Mitoxantrone—Headache—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000281	CcSEcCtD
Mitoxantrone—Nausea—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000266	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism—APOB—type 2 diabetes mellitus	7.32e-06	7.31e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.3e-06	7.29e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CALM1—type 2 diabetes mellitus	7.26e-06	7.25e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—type 2 diabetes mellitus	7.24e-06	7.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	7.23e-06	7.22e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	7.22e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.19e-06	7.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.17e-06	7.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOA1—type 2 diabetes mellitus	7.15e-06	7.14e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—type 2 diabetes mellitus	7.12e-06	7.11e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.09e-06	7.08e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	7.09e-06	7.08e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.09e-06	7.08e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	7.09e-06	7.08e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	7.08e-06	7.07e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	7.05e-06	7.04e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.02e-06	7.01e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.02e-06	7.01e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—LPL—type 2 diabetes mellitus	6.99e-06	6.98e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.99e-06	6.98e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GNB3—type 2 diabetes mellitus	6.99e-06	6.98e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—type 2 diabetes mellitus	6.95e-06	6.94e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	6.87e-06	6.86e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAT—type 2 diabetes mellitus	6.86e-06	6.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ADCY5—type 2 diabetes mellitus	6.84e-06	6.83e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPX1—type 2 diabetes mellitus	6.82e-06	6.81e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	6.8e-06	6.79e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	6.78e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	6.78e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	6.78e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.78e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	6.78e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.78e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—type 2 diabetes mellitus	6.74e-06	6.73e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	6.71e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	6.71e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	6.71e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	6.66e-06	6.65e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CD36—type 2 diabetes mellitus	6.64e-06	6.63e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	6.59e-06	6.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.57e-06	6.56e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.56e-06	6.55e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	6.53e-06	6.52e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	6.51e-06	6.5e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—type 2 diabetes mellitus	6.5e-06	6.49e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.49e-06	6.48e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	6.48e-06	6.47e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IRS1—type 2 diabetes mellitus	6.45e-06	6.44e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.39e-06	6.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	6.39e-06	6.38e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	6.36e-06	6.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.32e-06	6.31e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—type 2 diabetes mellitus	6.3e-06	6.29e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	6.23e-06	6.22e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	6.21e-06	6.2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.2e-06	6.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.2e-06	6.19e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	6.18e-06	6.17e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—INS—type 2 diabetes mellitus	6.18e-06	6.17e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARA—type 2 diabetes mellitus	6.18e-06	6.17e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.08e-06	6.07e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	6.08e-06	6.07e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.07e-06	6.06e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.07e-06	6.06e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	6.06e-06	6.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.05e-06	6.04e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	6.04e-06	6.03e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—type 2 diabetes mellitus	6e-06	5.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	5.99e-06	5.98e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AGT—type 2 diabetes mellitus	5.98e-06	5.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT2—type 2 diabetes mellitus	5.97e-06	5.97e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.97e-06	5.96e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.92e-06	5.91e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.9e-06	5.89e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CALM1—type 2 diabetes mellitus	5.88e-06	5.87e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—type 2 diabetes mellitus	5.86e-06	5.85e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	5.82e-06	5.81e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.82e-06	5.81e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOA1—type 2 diabetes mellitus	5.79e-06	5.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	5.78e-06	5.77e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	5.78e-06	5.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.77e-06	5.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.77e-06	5.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.77e-06	5.76e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	5.73e-06	5.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	5.68e-06	5.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.67e-06	5.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.64e-06	5.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.64e-06	5.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.64e-06	5.63e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	5.62e-06	5.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.6e-06	5.59e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.53e-06	5.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.53e-06	5.52e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.5e-06	5.49e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	5.44e-06	5.43e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.44e-06	5.43e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—type 2 diabetes mellitus	5.42e-06	5.41e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	5.42e-06	5.41e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	5.35e-06	5.34e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.34e-06	5.33e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	5.33e-06	5.32e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.32e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.32e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	5.28e-06	5.27e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	5.27e-06	5.26e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.23e-06	5.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—INS—type 2 diabetes mellitus	5.18e-06	5.17e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.14e-06	5.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.14e-06	5.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.14e-06	5.13e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—type 2 diabetes mellitus	5.1e-06	5.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.05e-06	5.05e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.05e-06	5.05e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.05e-06	5.05e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.02e-06	5.01e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	5.02e-06	5.01e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—INS—type 2 diabetes mellitus	5.01e-06	5e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.99e-06	4.99e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.96e-06	4.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	4.96e-06	4.95e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.93e-06	4.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.92e-06	4.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.83e-06	4.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.82e-06	4.81e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.81e-06	4.8e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.78e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	4.75e-06	4.74e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.65e-06	4.65e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	4.64e-06	4.64e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.62e-06	4.62e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—type 2 diabetes mellitus	4.59e-06	4.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.57e-06	4.56e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.57e-06	4.56e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.57e-06	4.56e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—INS—type 2 diabetes mellitus	4.55e-06	4.55e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.54e-06	4.53e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	4.54e-06	4.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.53e-06	4.52e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.47e-06	4.46e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.46e-06	4.45e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.46e-06	4.45e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—type 2 diabetes mellitus	4.39e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.39e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.38e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.38e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.37e-06	4.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.37e-06	4.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.37e-06	4.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.37e-06	4.36e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.34e-06	4.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.28e-06	4.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.19e-06	4.18e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	4.18e-06	4.17e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	4.15e-06	4.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	4.11e-06	4.11e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	4.03e-06	4.03e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—type 2 diabetes mellitus	4.02e-06	4.01e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SRC—type 2 diabetes mellitus	4.01e-06	4e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	3.99e-06	3.99e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.99e-06	3.99e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.91e-06	3.9e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.9e-06	3.89e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.84e-06	3.84e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.83e-06	3.82e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.78e-06	3.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.78e-06	3.77e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.78e-06	3.77e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.76e-06	3.75e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.71e-06	3.7e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.65e-06	3.65e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.64e-06	3.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.6e-06	3.6e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	3.58e-06	3.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.56e-06	3.56e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.56e-06	3.56e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—type 2 diabetes mellitus	3.51e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.5e-06	3.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.49e-06	3.49e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.47e-06	3.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.47e-06	3.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.47e-06	3.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.45e-06	3.45e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.44e-06	3.43e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.39e-06	3.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.37e-06	3.36e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.36e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.35e-06	3.34e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.33e-06	3.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.27e-06	3.27e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.27e-06	3.26e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.23e-06	3.22e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.11e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.11e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.11e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.1e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.06e-06	3.05e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.04e-06	3.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.03e-06	3.02e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	3e-06	2.99e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.96e-06	2.96e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.94e-06	2.94e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.89e-06	2.89e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.88e-06	2.88e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.87e-06	2.86e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.87e-06	2.86e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.85e-06	2.85e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.85e-06	2.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.82e-06	2.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.82e-06	2.81e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—type 2 diabetes mellitus	2.7e-06	2.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.7e-06	2.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.7e-06	2.7e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.62e-06	2.62e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.51e-06	2.51e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—type 2 diabetes mellitus	2.49e-06	2.49e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.46e-06	2.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.33e-06	2.32e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.33e-06	2.32e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.32e-06	2.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.29e-06	2.28e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.26e-06	2.25e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.22e-06	2.22e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.16e-06	2.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.16e-06	2.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.16e-06	2.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.12e-06	2.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	2.09e-06	2.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.07e-06	2.07e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.07e-06	2.06e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	2.02e-06	2.02e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.01e-06	2.01e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.99e-06	1.98e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.98e-06	1.97e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.91e-06	1.9e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.87e-06	1.87e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.84e-06	1.83e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.81e-06	1.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.78e-06	1.78e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.78e-06	1.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.76e-06	1.75e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.55e-06	1.54e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.52e-06	1.51e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.39e-06	1.39e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-06	1.33e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-06	1.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.32e-06	1.32e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.22e-06	1.22e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	9.93e-07	9.91e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.12e-07	6.11e-06	CbGpPWpGaD
